Cytosorbents CTSO
NASDAQ CTSO
$0.34 -0.01 (-3.63%)
At close: Aug 20, 2026 · 1:07 PM UTC

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016)

Cytosorbents' (CTSO) quarterly Change in Acquisitions & Divestments came in at $249000.0 in Q3 2016, down 83.33% YoY from $1.5 million in Q4 2015, and down 87.18% on a QoQ basis from $1.9 million in Q2 2016.

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016) Analysis & Trends

Cytosorbents (CTSO) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $249000.0 in Q3 2016.

  • Quarterly Change in Acquisitions & Divestments fell 83.33% year-over-year to $249000.0 in Q3 2016, while the trailing twelve-month figure through Dec 2017 was $2.2 million (changed 0.0% YoY) and the FY2016 annual result came in at $2.2 million, down 59.64% from the prior year.
  • Change in Acquisitions & Divestments slipped to $249000.0 in Q3 2016, from $1.9 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.9 million in Q2 2016 to a low of $249000.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 Cytosorbents 21.57 Mn 17.16 Mn 7.05 Mn

Historic Data

Download Data
DateValue
Sep 30, 2016 249,000.00
Sep 30, 2016 249,000.00
Jun 30, 2016 1.94 Mn
Jun 30, 2016 1.94 Mn
Dec 31, 2015 1.49 Mn
Dec 31, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Jun 30, 2015 1.20 Mn
Jun 30, 2015 1.20 Mn
Mar 31, 2015 1.25 Mn
Mar 31, 2015 1.25 Mn